药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Alphameprodine
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Gilteritinib.
Alphameprodine
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Gilteritinib.
Alphameprodine
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Gilteritinib.
Alphameprodine
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Gilteritinib.
Alphameprodine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Gilteritinib.
Alphameprodine
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Gilteritinib.
Alphameprodine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Gilteritinib.
Alphameprodine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Gilteritinib.
Alphameprodine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Gilteritinib.
Alphameprodine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Gilteritinib.
Alphameprodine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Gilteritinib.
Alphameprodine
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Gilteritinib.
Alphameprodine
Efonidipine
The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Gilteritinib.
Alphameprodine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Gilteritinib.
Alphameprodine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Gilteritinib.
Alphameprodine
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Gilteritinib.
Alphameprodine
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Gilteritinib.
Alphameprodine
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Gilteritinib.
Alphameprodine
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Gilteritinib.
Alphameprodine
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Gilteritinib.